# Evaluate the Side Effects and Benefits of RAS 130 With or Without Diet and Exercise in Type II Diabetes Mellitus

Study · id `cardio:ct-nct00737152` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT00737152](<https://clinicaltrials.gov/study/NCT00737152>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT00737152

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 460 participants.

## Technical summary

Registry record NCT00737152. Non-randomized; no masking; primary purpose treatment. Start 2011-07 (registry gives no type); primary completion 2014-04 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 460 participants (planned count; ClinicalTrials.gov record NCT00737152, source copy `cardio:ctgov-nct00737152-2011-07-20`, retrieved 2026-10-26)
- Start date: 2011-07 (registry gives no type) (ClinicalTrials.gov record NCT00737152, source copy `cardio:ctgov-nct00737152-2011-07-20`, retrieved 2026-10-26)
- Primary completion: 2014-04 (anticipated) (ClinicalTrials.gov record NCT00737152, source copy `cardio:ctgov-nct00737152-2011-07-20`, retrieved 2026-10-26)
- Completion: 2014-04 (anticipated) (ClinicalTrials.gov record NCT00737152, source copy `cardio:ctgov-nct00737152-2011-07-20`, retrieved 2026-10-26)
- Countries: United States; India (ClinicalTrials.gov record NCT00737152, source copy `cardio:ctgov-nct00737152-2011-07-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct00737152-2011-07-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluate the Side Effects and Benefits of RAS 130 With or Without Diet and Exercise in Type II Diabetes Mellitus
- Acronym: ASI-DMII
- Condition: Type II Diabetes Mellitus
- Intervention (Other): RAS 130 with diet and exercise
- Lead sponsor: American Scitech International
- Lead sponsor class: OTHER
- Collaborator: Proactive Clinical Research
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)

## Provenance

Content hash: 2e3f0594153c0a94ed73a61fd6a63f3e3a0689ebf1266c13678b30dad5424d3a
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
